Halıt Karaca
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
-
- Renal cell carcinoma treatment 4
- Gastric Cancer Management and Outcomes 4
- Occupational and environmental lung diseases 3
- Oncology 18
- Cancer Diagnosis and Treatment 3
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Velı Berk (18 shared papers)Ali Ergin (2 shared papers)Mahmut Akpek (3 shared papers)Nihat Kalay (3 shared papers)Metin Özkan (5 shared papers)Mustafa Dikilitaş (7 shared papers)Mevlüde İnanç (9 shared papers)Metin Özkan (24 shared papers)
In The Last Decade
Halıt Karaca
50 papers receiving 859 citations
Peers
Comparison fields: 5 of 82
- Cardiology and Cardiovascular Medicine 394
- Oncology 331
- Pulmonary and Respiratory Medicine 210
- Gastroenterology 25
- Pediatrics, Perinatology and Child Health 68
Countries citing papers authored by Halıt Karaca
This map shows the geographic impact of Halıt Karaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halıt Karaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halıt Karaca more than expected).
Fields of papers citing papers by Halıt Karaca
This network shows the impact of papers produced by Halıt Karaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halıt Karaca. The network helps show where Halıt Karaca may publish in the future.
Co-authors
The 25 scholars most cited alongside Halıt Karaca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 240 | |
| 2 | 2014 | 175 | |
| 3 | 2004 | 73 | |
| 4 | 2013 | 53 | |
| 5 | 2011 | 30 | |
| 6 | 2015 | 22 | |
| 7 | 2014 | 18 | |
| 8 | 2015 | 16 | |
| 9 | Co-existence of gastrointestinal stromal tumors with other primary neoplasms. | 2011 | 15 |
| 10 | 2015 | 15 | |
| 11 | 2010 | 15 | |
| 12 | 2012 | 14 | |
| 13 | 2016 | 12 | |
| 14 | 2012 | 12 | |
| 15 | 2009 | 10 | |
| 16 | 2013 | 10 | |
| 17 | 2016 | 9 | |
| 18 | 2012 | 9 | |
| 19 | 2014 | 8 | |
| 20 | 2016 | 8 |
About Halıt Karaca
Halıt Karaca is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Surgery and Cardiology and Cardiovascular Medicine, having authored 51 papers that have together received 882 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Diagnosis and Treatment (3 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Occupational and environmental lung diseases (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (394 citations), Oncology (331 citations), Pulmonary and Respiratory Medicine (210 citations), Gastroenterology (25 citations) and Pediatrics, Perinatology and Child Health (68 citations). Halıt Karaca has collaborated with scholars based in Türkiye, Hong Kong and Belgium. Frequent co-authors include Velı Berk, Ali Ergin, Mahmut Akpek, Nihat Kalay, Metin Özkan, Mustafa Dikilitaş, Mevlüde İnanç, Metin Özkan, Ersin Özaslan and Mikail Yarlıoğlueş. Their work appears in journals such as Medical Oncology, Journal of Cancer Research and Clinical Oncology, Journal of Clinical Oncology, International Journal of Cardiology and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.